Gefitinib alone versus gefitinib plus chemotherapy for non–small-cell lung cancer with mutated epidermal growth factor receptor: NEJ009 study

North-East Japan Study Group

Research output: Contribution to journalArticlepeer-review

114 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Gefitinib alone versus gefitinib plus chemotherapy for non–small-cell lung cancer with mutated epidermal growth factor receptor: NEJ009 study'. Together they form a unique fingerprint.

Medicine & Life Sciences